Population pharmacokinetics of caffeine in premature neonates

European Journal of Clinical Pharmacology

Volumn 52, Issue 3, 1997, Pages 211-217

  Falcao A C ^a   Fernandez De Gatta M M ^b   Delgado Iribarnegaray, M F ^b   Santos Buelga, D ^b   Garcia M J ^b   Dominguez Gil, A ^b   Lanao, J M ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Apnoea of prematurity; neonatology; Caffine; Paediatrics; Population pharmacokinetics

Indexed keywords

CAFFEINE;

ARTICLE; DATA ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PARENTERAL NUTRITION; PATIENT MONITORING; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; STATISTICAL ANALYSIS;

CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRATES; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MODELS, BIOLOGICAL; NEONATOLOGY; RISK FACTORS;

EID: 8544247247     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050276     Document Type: Article

References (34)

1. Sawynok J (1995) Pharmacological rationale for the clinical use of caffeine. Drugs 49: 37-50
2. Aranda JV, Gorman W, Bergsteinsson H, Gunn T (1977) Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90: 467-472
3. Murat I, Moriette G, Blin MC, Couchard M, Flouvat B, Gamarra E, Relier JP, Dreyfus-Brisac C (1981) The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 99: 984-989
4. Aranda JV, Turmen T, Davis J, Trippenbach T, Grondin D, Zinman R, Watters G (1983) Effect of caffeine on control of breathing in infantile apnea. J Pediatr 103: 975-978
5. Anwar M, Mondestin H, Mojica N, Novo R, Graff M, Hiatt M, Hegyi T (1986) Effect of caffeine on pneumogram and apnoea of infancy. Arch Dis Child 61: 891-895
6. Romagnoli C, Carolis MP, Muzii U, Zecca E, Tortorolo G, Chiarotti M, Giovanni N, Carnevale A (1992) Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants. Ther Drug Monitor 14: 14-19
7. Gorodischer R, Karplus M, Worszowski D, Bark H, Moses SW, Gordon C (1977) Caffeine pharmacokinetics in the neonate: human and animal studies. Pediatr Res 11: 1013
8. Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldrige A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 94: 663-668
9. Gorodischer R, Karplus M (1982) Pharmacokinetic aspects of caffeine in premature infants with apnoea. Eur J Clin Pharmacol 22: 47-52
10. Le Guennec JC, Billon B, Paré C (1985) Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding. Pediatrics 76: 834-840
11. Pearlman SA, Duran C, Wood MA, Maisels MJ, Berlin CM (1989) Caffeine pharmacokinetics in preterm infants older than 2 weeks. Dev Pharmacol Ther 12: 65-69
12. De Carolis MP, Romagnoli C, Muzii U, Tortorolo G, Chiarotti M, De Giovanni N, Carnevale A (1991) Pharmacokinetic aspects of caffeine in premature infants. Dev Pharmacol Ther 16: 117-122
13. Sheiner LB, Grasela TH (1991) An introduction to mixed effect modeling: concepts, definitions, and justification. J Pharmacokin Biopharm 19(Suppl): 11S-24S
14. Gilman JT, Gal P (1992) Pharmacokinetic and pharmacodynamic data collection in children and neonates: a quiet frontier. Clin Pharmacokin 23: 1-9
15. Sheiner LB, Beal S, Rosenberg B, Marathe VV (1979) Forecasting individual pharmacokinetics. Clin Pharmacol Ther 26: 294-305
16. Whiting B, Kelman AW, Grevel J (1986) Population pharmacokinetics: theory and clinical application. Clin Pharmacokin 11: 387-401
17. Beal SL, Sheiner LB (1989) NONMEM User's Guides. NONMEM project group. University of California, San Francisco
18. Miceli JN, Aravind MK, Ferrell WJ (1984) Analysis of caffeine: comparison of the manual enzyme multiplied immunoassay (EMIT), automated EMIT, and high-performance liquid chromatography procedures. Ther Drug Monitor 6: 344-347
19. Zysset T, Wahlländer A, Preisig R (1984) Evaluation of caffeine plasma levels by an automated enzyme immunoassay (EMIT) in comparison with a high-performance liquid chromatographic method. Ther Drug Monitor 6: 348-354
20. Aranda JV, Beharry K, Rex J, Johannes RJ, Charest-Boule L (1987) Caffeine enzyme immunoassay in neonatal and pediatric drug monitoring. Ther Drug Monitor 9: 97-103
21. Pons G, Carrier O, Richard MO, Rev E, d'Athis P, Moran C, Badoual J, Olive G (1988) Developmental changes of caffeine elimination in infancy. Dev Pharmacol Ther 11: 258-264
22. Thomson AH, Kerr S, Wright S (1996) Population pharmacokinetics of caffeine in neonates and young infants. Ther Drug Monitor 18: 245-253
23. Giacoia GP, Jungbluth GL, Jusko WJ (1989) Effect of formula feeding on oral absorption of caffeine in premature infants. Dev Pharmacol Ther 12:205-210
24. Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokin Biopharm 5: 445-479
25. Yamaoka H, Nakagawa T, Toyozo U (1978) Application of Akaike's Information Criterion (AIC) in the evaluation of linear equations. J Pharmacokin Biopharm 6: 165-175
26. Aldridge A, Aranda JV, Neims AH (1979) Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447-453
27. Gorodischer R, Zmora E, Ben-Zvi Z, Warswaski D, Yaari A, Sofer S, Arnaud MJ (1986) Urinary metabolites of caffeine in the premature infant. Eur J Clin Pharmacol 31: 497-499
28. Bada HS, Khanna NN, Somani SM (1979) Interconversion of theophylline and caffeine in newborn infants. J Pediatr 94: 993-995
29. Morselli PL, Franco-Morselli R, Bossi L (1980) Clinical pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clin Pharmacokin 5 485-527
30. Szefler SJ, Wynn RJ, Clarke DF, Buckwald S, Shen D, Schentag JJ (1980) Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates. J Pediatr 97: 312-315
31. Moore ES, Faix RG, Banagale RC, Grasela TH (1989) The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokin Biopharm 17: 47-66
32. Lhermitte M, Houdret N, Broly F, Roussel P (1987) Simultaneous administration of caffeine and phenobarbitone in infants with apnea. J Pediatr 10: 666-667
33. Yazdani M, Kissling GE, Tran TH, Gottschalk SK, Schut CR (1987) Phenobarbital increases the theophylline requirement of premature infants being treated for apnea. Am J Dis Child 141: 97-99
34. Ette EI, Kelman AW, Howie CA, Whiting B (1993) Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters. Ann Pharmacother 27: 1034-1039